Yi-Ching Wang
H指数:52
被引数:9,357
个人简介
Received a PhD in Genetics from Michigan State University, USA, in 1993, and completed postdoctoral training at the Institute of Biomedical Sciences, Academia Sinica. In 1995, appointed as Associate Professor at the Institute of Toxicology, Chung Shan Medical University, subsequently joined the Department of Life Science at National Taiwan Normal University and was promoted to Professor in 1999. Moved to the Department of Pharmacology, College of Medicine, National Cheng Kung University in 2006, served as a Distinguished Professor until 2015, and currently holds the position of Chair Professor at the same university. Research interests focus on elucidating molecular mechanisms underlying tumorigenesis in lung, esophageal, pancreatic, and colorectal cancers, specifically examining alterations in tumor suppressor genes and oncogenes that affect cancer signaling pathways. Key areas include cancer genomics, epigenomics, DNA methylation, chromatin remodeling, post-translational modifications, exocytosis, and the tumor microenvironment, with investigations into NRF2, Rab37, and stromal–cancer crosstalk.
教育背景
1993.12
Michigan State University 美國密西根大學
工作经历
2026.01 – 2028.12
National Science and Technology Council 國科會生科處
Convener, The Division of "Research in Pharmacy and Chinese Medicine" 藥學及中醫藥學學門 召集人
2015.01 – 至今
National Cheng Kung University 國立成功大學
2015.01 – 2018.12
The Taiwan Society For Biochemistry And Molecular Biology 台灣生化學會
2006.01 – 2015.12
National Cheng Kung University 國立成功大學
1999.01 – 至今
National Taiwan Normal University 國立台灣師範大學
1995.01 – 至今
Chung Shan Medical University 中山醫學大學
荣誉奖项
- The National Science and Technological Council Designated Research Fellow Award 國科會傑出特約研究員獎(2024)
- The 19th Tien Te Lee Biomedical Awards 第19屆永信李天德醫藥科技獎--卓越醫藥科技獎(2023)
- 66th Academic Award of Ministry of Education 第66屆教育部學術獎(2022)
- The Foundation for the Advancement of Outstanding Scholarship Award 傑出人才基金會傑出人才講座(2021-2023)|The Foundation for the Advancement of Outstanding Scholarship 傑出人才基金會
- K.T. Li Honorary Scholar Award, Taiwan 李國鼎科技與人文講座榮譽學者獎(2018)
- Dr. Wang Min-Ning Memory Foundation for Excellent Basic Medical Research award, Taiwan 財團法人王民寧先生紀念基金會【基礎醫學類】傑出貢獻獎(2017)
- Merit MOST Research Fellow Award, Taiwan科技部特約研究(2017~2023)
- Dr. Tung Ta-Cheng Memorial Award for Basic Cancer Research, Chinese Oncology Society, Taiwan 董大成博士癌症基礎醫學研究傑出獎(2013)
- Outstanding research award, Pharmacology Society, Taiwan藥理學會傑出研究獎(2008)
- Distinguished alumnus of Chinese Culture University, Taiwan 文化大學傑出校友(2007)
- NSC/MOST Excellent Research Award, Taiwan 國科會/科技部傑出研究獎(2004, 2010, 2014)
基质CCL2/CXCL10/SPARC轴驱动促肿瘤CHI3L1表达,以调节胰腺癌进展中的微环境及治疗创新
免疫检查点的翻译后修饰:分子机制、肿瘤微环境重塑及治疗意义
ONCOLOGY REPORTS
IF3.9
巨噬细胞活化决定胰腺癌中的肌肉消耗
Oncogene
IF7.3
被IL-6/STAT3激活的脱泛素化酶USP24增强了PD-1蛋白的稳定性并抑制了T细胞的抗肿瘤反应
SCIENCE ADVANCES
IF12.5
ADVANCED SCIENCE
IF14.1
血浆凝溶胶蛋白降低可促进纤维化肿瘤微环境并促进食管鳞状细胞癌的放化疗抵抗
CELL DEATH & DISEASE
IF9.6
IUBMB LIFE
IF3.2
CELL DEATH & DISEASE
IF9.6
金属有机骨架衍生的铜基电催化剂中的载体效应促进硝酸盐还原为氨
ELECTROCHIMICA ACTA
IF5.6
CELL DEATH & DISEASE
IF9.6
CANCER RESEARCH
IF16.6
CANCER RESEARCH
IF16.6

